Glycemic Exposure and Blood Pressure Influencing Progression and Remission of Diabetic Retinopathy
نویسندگان
چکیده
OBJECTIVE This study sought to investigate the progression and regression of diabetic retinopathy (DR) and the effects of population risk factors on the rates of transition across retinopathy stages. RESEARCH DESIGN AND METHODS The study cohort consisted of 44,871 observed DR events between the calendar years 1990 and 2011 for 4,758 diabetic patients who were diagnosed at 35 years of age or older. The first retinal observation was recorded within a year from diagnosis, and the result was recorded as free of retinopathy. A multistate Markov model was applied for analyzing the development of DR and its relation to the patterns of changes in risk factors. RESULTS We observed a consistent risk effect of HbA1c on the progression (no retinopathy to mild background DR [BDR] hazard ratio per SD of HbA1c [HR] 1.42 [95% CI 1.32-1.52], mild BDR to observable BDR HR 1.32 [95% CI 1.08-1.60], and observable BDR to severe nonproliferative/proliferative DR HR 2.23 [95% CI 1.16-4.29]). Similarly, systolic blood pressure (SBP) and diastolic blood pressure increased the risk for the transition from the asymptomatic phase to mild BDR (HR 1.20 [95% CI 1.11-1.30]) and the mild BDR to observable BDR (HR 1.87 [95% CI 1.46-2.40]), respectively. Regression from mild BDR to no DR was associated with lower SBP (HR 0.79 [95% CI 0.64-0.97]) and lower HbA1c (HR 0.76 [95% CI 0.64-0.89]). CONCLUSIONS Progression and regression of DR were strongly associated with blood pressure and glycemic exposure.
منابع مشابه
بررسی بروز 4 ساله رتینوپاتی دیابتی و عوامل مؤثر بر آن در دیابت نوع 2
Introduction: It seems that improvement in care and new treatment and screening methods along with better control of diabetes mellitus (DM) has led to a change in incidence of diabetic complications, especially diabetic retinopathy .This study was performed to assess the 4 years incidence rate of diabetic retinopathy in patients with type II diabetes and factors affecting its progression. Meth...
متن کاملMedical management of diabetic retinopathy: an overview.
Diabetes mellitus is a global health problem affecting 366 million people worldwide and its prevalence is growing rapidly. Diabetic eye disease is present in up to 25% of diabetic subjects. Diabetic retinopathy is a chronic complication of diabetes that can result in blindness. Generally, there are two stages of diabetic retinopathy, non-proliferative and proliferative. The longer a person has ...
متن کاملEffects of medical therapies on retinopathy progression in type 2 diabetes: Is blood pressure control the lower the better?
BACKGROUND We investigated whether intensive glycemic control, combination therapy for dyslipidemia, and intensive blood-pressure control would limit the progression of diabetic retinopathy in persons with type 2 diabetes. Previous data suggest that these systemic factors may be important in the development and progression of diabetic retinopathy. METHODS In a randomized trial, we enrolled 10...
متن کاملبررسی فراوانی و شدت رتینوپاتی دیابتی در بیماران بستری شده بهعلت عوارض غیرچشمی دیابت
Background: The aim of this study was to estimate the prevalence, severity, and risk factors for diabetic retinopathy in diabetic cases admitted for non-ocular diabetic complications and to investigate the association between retinopathy and these complications.Methods: In this cross-sectional study, 84 diabetic patients admitted to our university-affiliated hospital for non-ocular diabetic com...
متن کاملHas the frequency of proliferative diabetic retinopathy declined in the US?
R andomized controlled clinical trials provide evidence that intense glucose and blood pressure control result in a reduction in the incidence and progression of retinopathy and visual loss in people with diabetes (1–4). In the Diabetes Control and Complications Trial (DCCT) (1), intensive insulin treatment was found to reduce the risk of retinopathy progression in people with type 1 diabetes b...
متن کامل